The American Heart Association wants U.S. physicians to change the way they prescribe analgesics for patients with, or at risk for, heart disease.
The association said it based its recommendation on evidence that non-steroidal anti-inflammatory drugs, with the exception of aspirin, increase heart attack and stroke risks.
"We believe some physicians have been prescribing the new COX-2 inhibitors as the first line of treatment," said Dr. Elliott Antman, lead author of the association's statement and a professor at Harvard Medical School. "We are ... saying that, for chronic pain in patients with known heart disease or who are at risk for heart disease, these drugs should be the last line of treatment."
The AHA suggested physicians consider acetaminophen, aspirin and even short-term use of narcotic analgesics as the first step.
"If further relief is needed, physicians should suggest the least selective COX-2 inhibitors first, moving progressively toward more selective COX-2 inhibitors, which are at the bottom of the list, only if needed," the association said, noting all drugs should be used at the lowest dose necessary.
The full position statement appears in the journal Circulation.
Copyright 2007 by United Press International
Related stories:
A new century of Alzheimer's disease research
Imagine the day when a routine visit to the family doctor includes a simple blood test to predict the risk for developing Alzheimer’s disease (AD). If the test returns a worrisome result -- too many sticky brain proteins that might begin to gum up memory and thought in 10 to 15 years -- a person could be offered an aspirin-like pill to keep those proteins in check.
Global study shows telmisartan reduces outcome of cardiovascular death, heart attack or stroke
An international study led by Canadian researchers has found that telmisartan, a medication used to lower blood pressure, reduced the outcome of cardiovascular death, heart attack or stroke in people who are unable to tolerate a widely available and effective standard treatment.
Tiny 3-D ultrasound probe guides catheter procedures
An ultrasound probe small enough to ride along at the tip of a catheter can provide physicians with clearer real-time images of soft tissue without the risks associated with conventional x-ray catheter guidance.
Heart attack patients who stop statin risk death, say researchers
Patients discontinuing statin medication following an acute myocardial infarction (AMI) increase their risk of dying over the next year, say researchers at McGill University and the McGill University Health Centre (MUHC). Their study was published in a recent issue of the
European Heart Journal.
Newer cardiac imaging machines effective in detecting coronary artery stenosis
The first multicenter study of the accuracy of some of the latest cardiac imaging technology found it was 99 percent as effective in ruling out obstructive coronary artery stenosis - or narrowing of these arteries – as the more expensive and invasive coronary angiography traditionally used by physicians, according to research published online by the
Journal of the American College of Cardiology.
California tobacco control program saved billions in medical costs
California's state tobacco control program saved $86 billion--in 2004 dollars--in personal healthcare costs in its first 15 years, according to a study by researchers at the University of California, San Francisco.
Researchers define characteristics, treatment options for XXYY syndrome
Researchers at the UC Davis M.I.N.D. Institute and The Children's Hospital in Denver have conducted the largest study to date describing the medical and psychological characteristics of a rare genetic disorder in which males have two "X" and two "Y" chromosomes, rather than the normal one of each. The study, published in the June 15, 2008, issue of the
American Journal of Medical Genetics Part A, also offers treatment recommendations for men and boys with the disorder.
New reasons to avoid grapefruit and other juices when taking certain drugs
Scientists and consumers have known for years that grapefruit juice can increase the absorption of certain drugs — with the potential for turning normal doses into toxic overdoses. Now, the researcher who first identified this interaction is reporting new evidence that grapefruit and other common fruit juices, including orange and apple, can do the opposite effect by substantially decreasing the absorption of other drugs, potentially wiping out their beneficial effects.